The first participant has been vaccinated in Tumaini, a pivotal Phase 2/3 clinical trial of vaccine candidates against Bundibugyo virus (BDBV). The vaccination, administered on 23 October 2026 in Bunia, DRC marks the start of the trial, which will support the Government-led response to the ongoing outbreak. The trial begins as the DRC faces the […]
